BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21936894)

  • 1. Promoter methylation and downregulation of SLC22A18 are associated with the development and progression of human glioma.
    Chu SH; Feng DF; Ma YB; Zhang H; Zhu ZA; Li ZQ; Jiang PC
    J Transl Med; 2011 Sep; 9():156. PubMed ID: 21936894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 5-Aza-2'-deoxycytidine on SLC22A18 in glioma U251 cells.
    Chu SH; Ma YB; Feng DF; Zhang H; Qiu JH; Zhu ZA
    Mol Med Rep; 2012 Jan; 5(1):138-41. PubMed ID: 21993522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of SATB1 is associated with the development and progression of glioma.
    Chu SH; Ma YB; Feng DF; Zhang H; Zhu ZA; Li ZQ; Jiang PC
    J Transl Med; 2012 Jul; 10():149. PubMed ID: 22839214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo radiosensitization of human glioma U251 cells induced by upregulated expression of SLC22A18.
    Chu SH; Zhou ZM; Karri S; Li ZQ; Zhao JM
    Cancer Gene Ther; 2014 Mar; 21(3):103-9. PubMed ID: 24481489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of the SLC22A18 protein expression in glioblastoma patients receiving temozolomide therapy.
    Chu SH; Ma YB; Feng DF; Li ZQ; Jiang PC
    J Transl Med; 2013 Mar; 11():69. PubMed ID: 23514245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation Status of the RIZ1 Gene Promoter in Human Glioma Tissues and Cell Lines.
    Zhang C; Meng W; Wang J; Lu Y; Hu G; Hu L; Ma J
    Cell Mol Neurobiol; 2017 Aug; 37(6):1021-1027. PubMed ID: 27757741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of neogenin accelerated glioma progression through promoter Methylation and its overexpression in SHG-44 Induced Apoptosis.
    Wu X; Li Y; Wan X; Kayira TM; Cao R; Ju X; Zhu X; Zhao G
    PLoS One; 2012; 7(5):e38074. PubMed ID: 22666451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of HTATIP2 expression is associated with promoter methylation and poor prognosis in glioma.
    Dong X; Deng Q; Nie X; Zhang M; Jia W; Chen C; Xu C; Xu R
    Exp Mol Pathol; 2015 Apr; 98(2):192-9. PubMed ID: 25617528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The methylation and mRNA expression of SLC5A8 and TMS1/ASC genes in human glioma].
    Jiang Z; Li XG; Hu J; Lu DR; Zhou W; Jiang YQ; Li CY
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(5):292-7. PubMed ID: 17456354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced T-cadherin expression and promoter methylation are associated with the development and progression of hepatocellular carcinoma.
    Yan Q; Zhang ZF; Chen XP; Gutmann DH; Xiong M; Xiao ZY; Huang ZY
    Int J Oncol; 2008 May; 32(5):1057-63. PubMed ID: 18425332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analysis using methylation and gene expression microarrays reveals PDE4C as a prognostic biomarker in human glioma.
    Bao Z; Feng Y; Wang H; Zhang C; Sun L; Yan Z; Liu Q; Guo T; Li M; Yang X; Jiang C; Zhang Q; Jiang T
    Oncol Rep; 2014 Jul; 32(1):250-60. PubMed ID: 24842301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells.
    Zhou D; Wan Y; Xie D; Wang Y; Wei J; Yan Q; Lu P; Mo L; Xie J; Yang S; Qi X
    Exp Mol Med; 2015 Sep; 47(9):e182. PubMed ID: 26337869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation-induced silencing of maspin contributes to the proliferation of human glioma cells.
    Xu L; Liu H; Yu J; Wang Z; Zhu Q; Li Z; Zhong Q; Zhang S; Qu M; Lan Q
    Oncol Rep; 2016 Jul; 36(1):57-64. PubMed ID: 27177016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAGED4 expression in glioma and upregulation in glioma cell lines with 5-aza-2'-deoxycytidine treatment.
    Zhang QM; Shen N; Xie S; Bi SQ; Luo B; Lin YD; Fu J; Zhou SF; Luo GR; Xie XX; Xiao SW
    Asian Pac J Cancer Prev; 2014; 15(8):3495-501. PubMed ID: 24870746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas.
    Li J; Bian EB; He XJ; Ma CC; Zong G; Wang HL; Zhao B
    Int J Oncol; 2016 Feb; 48(2):723-33. PubMed ID: 26676363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome.
    Bai Y; Zhang QG; Wang XH
    Eur J Med Res; 2014 Dec; 19(1):66. PubMed ID: 25498217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation-mediated caspase-8 downregulation is associated with anti-apoptotic activity and human malignant glioma grade.
    Teng Y; Dong YC; Liu Z; Zou Y; Xie H; Zhao Y; Su J; Cao F; Jin H; Ren H
    Int J Mol Med; 2017 Mar; 39(3):725-733. PubMed ID: 28204824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Cancer Effects and Tumor Marker Role of Glutathione
    Jou YC; Wang SC; Dia YC; Wang ST; Yu MH; Yang HY; Chen LC; Shen CH; Liu YW
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XAF1 is frequently methylated in human esophageal cancer.
    Chen XY; He QY; Guo MZ
    World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.